VITAS Healthcare (CHE): Market Capitalization-to-Revenue Ratio

Corporate company logo of Roto-Rooter (CHE)

Chemed Corporation (CHE) is modernizing palliative care standards through Vitas by implementing monitoring systems. The P/S trajectory is available in the GURU.Markets terminal, where the 2.70 mark characterizes this parameter. The business relies on stable cash flow from hospices and the Roto-Rooter plumbing network. However, wage inflation and labor shortages are putting pressure on the margins of the medical segment.

VITAS Healthcare (CHE) - Price-to-Revenue Ratio from 07/04/2022 to 11/13/2026

Analytical breakdowns for VITAS Healthcare (CHE)

- current quotes and average value forecast:
Market Price chemed.com|CHE - Price Target Chart
- stock exchange capitalization data:
Market Value VITAS Healthcare|CHE - Total Company Value
- book capitalization indicators:
Share Book Value Chemed|CHE - Company Book Value|Market-to-Book Ratio chemed.com|CHE - Aggregate Company Assets
- issuer credit burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Chemed Corporation|CHE - Long-Term Debt to Capital|Short-Term Debt to Capital Chemed Corp|CHE - Company Total Debt|Debt to Book Capital VITAS Healthcare|CHE - Company Long-Term Debts|Short-Term Debt Volume Chemed|Immediate Liquidity chemed.com
- earnings and valuation multiples indicators:
CHE - Company Net Income|Net Profit Forecast Chemed Corporation|CHE - P/E Multiple|Projected Price to Earnings Roto-Rooter|CHE - PEG Multiple|Business Value to Operating Income Before Depreciation VITAS Healthcare|CHE - Operating profit EBITDA|Net earnings per one share for the last twelve months Chemed|CHE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months chemed.com|CHE - Earnings growth in current year|Earnings growth forecast for next year Chemed Corporation
- total revenue and sales volume data:
CHE - Company Revenue|Company Future Revenue chemed.com|CHE - P/S Multiple|Market Cap to Future Revenue Ratio VITAS Healthcare
Summary company analytics:chemed.com
Finished products of VITAS Healthcare

This metric smooths out the inertia of quarterly reporting by measuring the current market value of each unit of revenue to identify hidden overvaluation in share prices. The assessment of cost optimization efficiency through the outsourcing of IT platforms and equipment directly impacts sales margins, making the capitalization-to-revenue ratio a key indicator of fair pricing for Chemed Corporation (CHE) shares.

Competing companies

ELV - Price to Sales|Price-to-Revenue Ratio Service Corporation International SCI|Market Capitalization-to-Revenue Ratio ENSG|BFAM - Price-to-Revenue Ratio|Price-to-Sales Ratio BTSG|Alignment Healthcare (ALHC) - Price-to-Revenue Ratio|Price to Sales addus.com (ADUS)|Price-to-Revenue Ratio Brookdale|NHC: Market Capitalization-to-Revenue Ratio|P/S Multiple PACS|P/S Multiple Guardian Pharmacy Corp (GRDN)|Aveanna Healthcare - Market Cap to Revenue|Market Cap to Sales Volume LTC (LTCreit.com)|Healthcare Services Group - P/S Multiple|Price-to-Revenue Coefficient Matthews International Corp MATW|Carriage Services Corp (CSV) - Price-to-Revenue Ratio|Price to Sales InnovAge Health (INNV)|Price-to-Revenue Ratio Sonida Senior Living|Market Cap to Revenue Ratio EHAB (ehab.com)|P/S Multiple EJH|Market Cap to Revenue amedisys.com AMED